Medical devices are made of metals, such as stainless steel, aluminum, and ceramic. Many of these materials are not compatible with body tissues and fluids and can cause complications such as infections and blood clots. According to the Centers for Disease Control and Prevention (CDC), around 2,000,000 patients contract hospital-acquired infections (HAIs) every year in the U.S., resulting in 100,000 deaths; HAIs cost the U.S. healthcare system an estimated USD 45 billion annually. In addition, according to the European Centre for Disease, around 4,131,000 patients suffer from healthcare-associated infections every year in Europe. Rise in incidence of HAIs is a major challenge for healthcare providers; therefore, antimicrobial coatings have gained importance in recent years.
Factors such as rising awareness about HAIs, favorable research and funding environment, technological advancements, growing implantable devices market, increasing research and development activities for antimicrobial-coated cardiovascular devices, high growth in geriatric population, and increasing burden of cardiovascular diseases across the globe are driving the growth of the medical device antimicrobial coatings market. However, certain barriers such as limitations of silver ion coatings, time- and resource-intensive processes for development and approval of antimicrobial coating products, and unfavorable healthcare reforms in the U.S. are hindering growth of this market.
The research findings cited in this report encapsulate activities associated with designing a business, purchasing raw materials, manufacturing of products, finding and reaching customers, transacting a sale, distributing a product, or delivering a service. Manufacturing capabilities, R&D capabilities, logistic capabilities, distributor/supplier/sales channel networks, marketing & promotional activities, key resources, value propositions, key growth strategies, customer orientation/customer relationship management, pre- & post-sales services, customer segments, offices & warehouses, cost structures, and revenue streams, among other factors are some of the key attributes that are discussed at length in this report.
Manufacturers, start-up firms/entrepreneurs, resellers/channel partners/distributors (citing backward integration), market research & business consulting firms, and venture capitalists/investment firms are some of the key stakeholders who are likely to benefit from the business models of market players. The business model can help well-established/leading players and manufacturers in the industry to gauge competitor moves, align or re-align its business strategies to combat competition, or to create new growth engines. Start-ups companies/entrepreneurs can utilize business models to benchmark their offerings/services vis-à-vis competitors/leading players. It gives them a direction as to how to plan their business, and whether to enter a contested or uncontested space. Business models can incentivize resellers/channel partners/distributors who are eyeing backward integration to gain dominance in their businesses. Market research & business consulting firms can use these business models for validation of their research findings, and for consultation to third parties. Venture capital is invested in exchange for an equity stake in the business. A business model may serve as a stepping stone in ascertaining which companies (operating in particular market) would be ideal for investing.
Scope of the Report
This report provides a qualitative assessment of the business models of antimicrobial coatings for medical devices companies in terms of key partners, key activities, key resources, value propositions, channels, customer segments, customer relationships, revenue streams, and competitive strategy, amongst others.
Business Model Analysis, by Company
Business model analysis on following indicative parameters can be carried for Covalon Technologies Ltd. (Canada), and The Dow Chemical Company (U.S.):
Medical devices are made of ceramic materials and metals such as stainless steel and aluminum. Many of these materials are not compatible with body tissues and fluids and can cause complications such as infections and blood clots. According to the Centers for Disease Control and Prevention (CDC), an estimated 2,000,000 patients contract hospital acquired infections (HAIs) every year in the U.S., resulting in 100,000 deaths; HAIs cost the U.S. healthcare system an estimated USD 45 Billion annually. In addition, according to the European Centre for Disease, 4,131,000 patients suffer from HAIs every year in Europe. The growing incidence of HAIs is a major challenge for healthcare providers, and hence antimicrobial coatings have gained importance in recent years.
Globally, incessant research for fulfilling the requirement of highly biocompatible coatings for reducing the risk of infections is a pivotal factor that is stimulating the growth of the global antimicrobial coatings market for medical devices. This has led to the development of metallic (including silver, copper, and zinc) and non-metallic coatings (polymers and organic coatings).
The report provides in-depth assessment of the business models of leading companies (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE) operating in the antimicrobial coatings market for medical devices.
A business model is a plan implemented by a company to generate revenue and earn profits from operations. It includes all activities associated with designing a business, purchasing raw materials, manufacturing of products, finding and reaching customers, transacting a sale, distributing a product, or delivering a service. Manufacturing capabilities, R&D capabilities, logistic capabilities, distributors/suppliers/sales channel networks, marketing & promotional activities, key resources, value propositions, key growth strategies, customer orientation/customer relationship management, pre- & post-sales services, customer segments, offices & warehouses, cost structures, and revenue stream, among other factors are taken into consideration while formulating a business model.
A business model can be beneficial for the following stakeholders:
Table of Content
1 Business Model Analysis in Antimicrobial Coatings for Medical Devices Market (Page No. - 8)
1.1 Antimicrobial Coatings for Medical Device Market
1.1.2 Prominent Players
1.2 Business Model
1.2.2 Essence of Business Model
1.3 Business Model Analysis By Companies
1.3.1 Specialty Coating Systems, Inc. (SCS) (U.S.)
22.214.171.124 Key Partners
126.96.36.199 Key Activities
188.8.131.52 Key Resources
184.108.40.206 Value Propositions
220.127.116.11 Customer Segments
18.104.22.168 Customer Relationships
22.214.171.124 Revenue Streams
126.96.36.199 Competitive Strategy
1.3.2 Royal DSM (The Netherlands)
188.8.131.52 Key Partners
184.108.40.206 Key Activities
220.127.116.11 Key Resources
18.104.22.168 Value Propositions
22.214.171.124 Customer Segments
126.96.36.199 Customer Relationships
188.8.131.52 Revenue Streams
184.108.40.206 Competitive Strategy
1.3.3 Hydromer, Inc. (U.S.)
220.127.116.11 Key Partners
18.104.22.168 Key Activities
22.214.171.124 Key Resources
126.96.36.199 Customer Segments
188.8.131.52 Value Propositions
184.108.40.206 Customer Relationship
220.127.116.11 Revenue Streams
18.104.22.168 Competitive Strategy
1.3.4 PPG Industries, Inc. (U.S.)
22.214.171.124 Key Partners
126.96.36.199 Key Activities
188.8.131.52 Key Resources
184.108.40.206 Value Propositions/ Revenue Streams
220.127.116.11 Customer Segments
18.104.22.168 Customer Relationships
22.214.171.124 Competitive Strategy
1.3.5 BASF SE (U.S.)
126.96.36.199 Key Partners
188.8.131.52 Key Activities
184.108.40.206 Key Resources
220.127.116.11 Value Propositions/Revenue Streams
18.104.22.168 Customer Relationships
22.214.171.124 Competitive Strategy
List of Tables (9 Tables)
Table 1 Indicative List of Suppliers/Distributors of Final Products of SCS
Table 2 List of Upcoming Trade Shows (2015) Where SCS Will Participate
Table 3 List of Webinars/Conferences/Exhibitions (2015) Where SCS Will Participate & has Participated
Table 4 List of Parylene Applications, By Industry
Table 5 List of Comforcoat Applications
Table 6 Indicative List of Hydromer’s Dealers
Table 7 Indicative List of Suppliers for PPG Industries, Inc. (Industrial Coatings Business)
Table 8 List of Hygentic Range of Compounds Applications
Table 9 R&D Landscape of BASF in 2014
List of Figures (12 Figures)
Figure 1 Parameters for Studing Business Model
Figure 2 Business Model: Specialty Coating Systems, Inc.
Figure 3 Organic & Inorganic Growth Strategies: Industry vs Specialty Coating Systems, Inc.
Figure 4 Business Model: Royal DSM
Figure 5 Organic & Inorganic Growth Strategies: Industry vs Royal DSM
Figure 6 Business Model: Hydromer, Inc.
Figure 7 Indicative List of Hydromer’s Clientele
Figure 8 Organic & Inorganic Growth Strategies: Industry vs Hydromer
Figure 9 Business Model: PPG Industries, Inc.
Figure 10 Organic & Inorganic Growth Strategies: Industry vs PPG Industries, Inc.
Figure 11 Business Model: BASF SE
Figure 12 Organic & Inorganic Growth Strategies: Industry vs BASF SE
Benchmarking the rapid strategy shifts of the Top 100 companies in the Business Model Analysis in Antimicrobial Coatings for Medical DevicesRequest For Special Pricing